Translocations and deletions of 5q13.1 in myelodysplasia and acute myelogenous leukemia: Evidence for a novel critical locus

Blood

Volumn 88, Issue 6, 1996, Pages 2259-2266

  Fairman, Jeffery ^b   Wang, Rui Yu ^b   Liang, Hong ^b   Zhao, Lian ^b   Saltman, David ^b   Liang, Jan C ^b   Nagarajan, Lalitha ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER GENETICS; CHROMOSOME 5Q; CHROMOSOME DELETION 5; CHROMOSOME TRANSLOCATION 5; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; GENE LOCUS; GENE LOSS; HUMAN; MALE; MYELODYSPLASIA; PRIORITY JOURNAL;

EID: 9544254827     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.6.2259.bloodjournal8862259     Document Type: Article

References (29)

1. Mecucci C, Van den Berghe H: Cytogenetics. Hematol/Oncol Clin N Am 6:523, 1992
2. Boultwood J, Lewis S, Wainscoat JS: The 5q- syndrome. Blood 84:3253, 1994a
3. Nagarajan L: Molecular analysis of 5q- chromosome. Leuk Lymph 17:361, 1995
4. Pedersen B, Jensen IM: Clinical and prognostic implications of chromosome 5q deletions: 96 high resolution studied patients. Leukemia 5:566, 1991
5. Dewald GW, Davis MP, Pierre RV, O'Fallon JR, Hoagland HC: Clinical characteristics and progress of 50 patients with a myeloproliferative syndrome and deletion of part of the long arm of chromosome 5. Blood 66:189, 1985
6. Le Beau, M.M., Espinosa R III, Neuman WL, Stock W, Roulston D, Larson, RA, Keinanen M, Westbrook CA: Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc Natl Acad Sci USA 90:5484, 1993
7. Nagarajan L, Zavadil J, Claxton D, Lu X, Fairman J, Warrington JA, Wasmuth JJ, Chinault AC, Sever CE, Slovak ML, Willman CL, Deisseroth AB: Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in patients with 5q- chromosome. Blood 83:199, 1994a
8. Fairman J, Chumakov I, Chinault C, Nowell PC, Nagarajan L: Physical mapping of the critical 5q31 locus. Proc Natl Acad Sci USA 92:7406, 1995
9. Boultwood J, Fidler C, Lewis S, Kelly S, Sheridan H, Littlewood TJ, Buckle VJ, Wainscoat JS: Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q-syndrome: Delineation of the critical region on 5q and identification of a 5q- breakpoint, Genomics 19:425, 1994
10. Van Den Berghe H, Vermaelen K, Mecucci C, Barbieri D, Tricot G: The 5q- anomaly. Cancer Genet Cytogenet 17:189, 1985
11. Mecucci C, Van den Berghe H, Michaux JL, Bosly A, Doyen: Paracentric inversions on the long arm of chromosome 5 in secondary myelodysplastic disorders. Cancer Genet Cytogenet 29:171, 1987
12. Vandenberghe EA, Mecucci C, Delannoy A, Van Den Berghe H: Deletion of 5q by t(5;17) in therapy-related myelodysplastic syndrome. Cancer Genet Cytogenet 48:49, 1990
13. Thangavelu M, Bitter MA, Larson RA, Davis EM, Rowley JD, Le Beau MM: der(5)t(5;7)(q11.2′1.2): A new recurring abnormality in malignant myeloid disorders. Cancer Genet Cytogenet 37:1, 1989
14. Kroef, MJ PL, Fibbe WE, Mout R, Jansen RPM, Haak HL, Wessels JW, Van Kamp H, Willemze R, Landegent JE: Myeloid but not lymphoid cells carry the 5q deletion: Polymerase chain reaction analysis of loss of heterozygosity using mini-repeat sequences on highly purified cell fractions. Blood 81:1849, 1993
15. Chumakov IM, Rigault P, Le Gall I, Bellanne-Chantelot C, Billault A, Guillou S, Soularue P, Guasconi G, Poullier E, Gros I, Belova M, Sambucy J-L, Susini L, Gervy P, Gilbert F, Beaufils S, Bui H, Massart C, De Tand M-F, Dukasz F, Lecoulant S, Ougen P, Perrot V, Saumier M, Soravito C, Bahouayila R, Cohen-Akenine A, Barillot Em, Bertrand S, Codani J-J, Caterina D, Georges I, Lacroix B, Lucotte G, Sahbatou M, Schmit C, Sangouard M, Nguyen S, Muselet D, Vignal A, Morissette J, Menninger J, Lieman J, Desai T, Banks A, Bray-Ward P, Ward D, Hudson T, Gerety S, Foote S, Stein L, Page DC, Lander ES, Weissenbach J, Le Paslier D, Cohen D: A YAC contig map of the human genome. Nature 377:175, 1995
16. Fairman J, Claxton D, Willman CL, Deisseroth AB, Nagarajan L: Development of a sensitive PCR to detect allele loss in a model hematopoietic neoplasm. PCR Methods Applications 4:6, 1994
17. Trujillo JM, Cork A, Aheam MJ, Younes EL, McCredie KB: Hematologic and cytologic characterization of 8;21 translocation acute granulocytic leukemia. Blood 53:695, 1979
18. Dana S, Wasmuth JJ: Linkage of the leuS, emtB, and chr genes on chromosome 5 in humans and expression of human genes encoding protein synthetic components in Human-Chinese hamster hybrids. Som Cell Genet 8:245, 1982
19. Roy N, McLean MD, Besner-Johnston A, Lefebvre C, Salih M, Carpten JD, Burghes AHM, Yaraghi Z, Ikeda J, Korneluk RG, MacKenzie AE: Refined physical map of the spinal muscular atrophy gene (SMA region at 5q13 based on YAC and cosmid contiguous arrays). Genomics 26:451, 1995
20. Philippsen P, Stotz A, Scherf C: DNA of Saccharomyces cerevisiae, in Guthrie G, Fink RJ (eds): Guide to Yeast Genetics. New York, NY, Academic, 1991, p 169
21. Liu P, Siciliano J, Seong D, Craig J, Zhao Y, de Jong PJ, Siciliano M: Dual Alu polymerase chain reaction primers and conditions for isolation of human chromosome painting probes from hybrid cells. Cancer Genet Cytogenet 65:93, 1993
22. Zhao L, van Oort J, Cork A, Liang JC: Comparison between interphase and metaphase cytogenetics in detecting chromosome 7 defects in hematological neoplasias. Am J Hematol 43:205, 1993
23. Huebner K, Nagarajan L, Besa E, Angert E, Lange BJ, Cannizzaro LA, van den Berghe H, Santoli D, Finan J, Croce CM, Nowell PC: Order of genes on human chromosome 5q with respect to 5q interstitial deletions. Am J Hum Genet 46:26, 1990
24. Lu-Kuo JM, Le Paslier D, Weissenbach J, Chumakov I, Cohen D, Ward DC: Construction of a YAC contig and a STS map spanning at least seven megabasepairs in chromosome 5q34-35. Hum Mol Genet 3:99-106, 1994
25. Nucifora G, Rowley JD: AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 86:1, 1995
26. Rowley JD: 1993 American Society of Human Genetics Presidential Address: Can we meet the challenge? Am J Hum Genet 54:403, 1994
27. Cawthon RM, Weiss R, Xu G, Viskochil D, Culver M, Stevens J, Robertson M, Dunn D, Gesteland R, O'Connell P, White R: A major segment of the neurofibro-matosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 62:193, 1990
28. Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL, Brownstein BH, Collins FS: Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients. Science 249:181, 1990
29. Nagarajan L, Zhao L, Lu X, Warrington JA, Wasmuth JJ, Siciliano M, Deisseroth AB, Liang JC: 5q- chromosome: Evidence for complex interstitial breaks in a case of refractory anemia with excess blasts. Cancer Genet Cytogenet 74:8, 1994